SACS Rabbit Polyclonal Antibody($99/20μL)

SACS Rabbit Polyclonal Antibody($99/20μL)

Cat: APRab17571
Size:20μL Price:$99
Size:50μL Price:$118
Size:100μL Price:$220

Size:200μL Price:$380
Application:IHC,ICC/IF

Reactivity:Human,Mouse
Conjugate:Unconjugated
Optional conjugates: Biotin, FITC (free of charge).
See other 26 conjugates.

Gene Name:SACS Category: Polyclonal Antibody Tags: , , , , , , , , , , , ,

Summary

Production Name

SACS Rabbit Polyclonal Antibody

Description

Rabbit polyclonal Antibody

Host

Rabbit

Application

IHC,ICC/IF

Reactivity

Human,Mouse

 

Performance

Conjugation

Unconjugated

Modification

Unmodified

Isotype

IgG

Clonality

Polyclonal

Form

Liquid

Storage

Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.

Buffer

Liquid in PBS containing 50% glycerol, and 0.02% New type preservative N.

Purification

Affinity purification

 

Immunogen

Gene Name

SACS

Alternative Names

KIAA0730

Gene ID

26278

SwissProt ID

Q9NZJ4

 

Application

Dilution Ratio

IHC 1:50-1:300,ICC/IF 1:50-1:200

Molecular Weight

503kDa

 

Background

This gene encodes the sacsin protein, which includes a UbL domain at the N-terminus, a DnaJ domain, and a HEPN domain at the C-terminus. The gene is highly expressed in the central nervous system, also found in skin, skeletal muscles and at low levels in the pancreas. This gene includes a very large exon spanning more than 12.8 kb. Mutations in this gene result in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS), a neurodegenerative disorder characterized by early-onset cerebellar ataxia with spasticity and peripheral neuropathy. The authors of a publication on the effects of siRNA-mediated sacsin knockdown concluded that sacsin protects against mutant ataxin-1 and suggest that "the large multi-domain sacsin protein is able to recruit Hsp70 chaperone action and has the potential to regulate the effects of other ataxia proteins" (Parfitt et al., PubMed: 19208651).disease:Defects in SACS are the cause of autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) [MIM:270550]. ARSACS is an early onset neurodegenerative disease with high prevalence in the Charlevoix-Saguenay-Lac-Saint-Jean region of Quebec. It is characterized by absent sensory-nerve conduction, reduced motor-nerve velocity and hypermyelination of retinal-nerve fibers.,function:May function in chaperone-mediated protein folding.,similarity:Contains 1 HEPN domain.,similarity:Contains 1 J domain.,tissue specificity:Highly expressed in the central nervous system. Also found in skeletal muscle and at low levels in pancreas.,

 

Research Area

Epigenetics and Nuclear Signaling; Transcription; Domain Families; HLH / Leucine Zipper; Leucine Zipper; Signal Transduction; Protein Trafficking; Chaperones; Other Chaperones; Metabolism; Pathways and Processes; Mitochondrial Metabolism; Mitochondrial markers

   💬 WhatsApp